TuHURA BIOSCIENCES, INC./NV Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, value, new issues for the quarter ending 2025-09-30 was $2.65M.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, value, new issues for the quarter ending 2025-06-30 was $8.20M.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, value, new issues for the quarter ending 2013-09-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, value, new issues for the quarter ending 2013-06-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV stock issued during period, value, new issues for fiscal 2024 was -$1.35M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-09-30 | $2.65M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $8.20M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | -$1.35M 10-K · filed 2026-03-31 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | |
| 2013-03-31 | $598.00K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |